SCHEMBL310552

SCHEMBL310552

CCCCCCCCCCC(C)(C)C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FDPS P14324 10/20 0.47
SMPD1 P17405 2/20 0.47
CES2 O00748 1/20 0.47
GGPS1 O95749 6/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31447903 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL75740 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL31448016 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL3969522 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL2351092 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL7104154 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL31447926 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL547320 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL373955 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1
SCHEMBL7157213 1.00 FDPS (0.47) FDPSSMPD1CES2GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743050-A1 3-HYDROXYPROPYLESTERS AS FOAM AND VISCOSITY MODULATING AGENTS IN SURFACTANT CONTAINING FORMULATIONS Symrise AG (DE) 2026-05-20 EP claimed
US-12486472-B2 Concentrated liquid esterquat compositions STEPAN COMPANY (US) 2025-12-02 US claimed
CN-120021411-A Mixture comprising climbazole with improved foam volume and foam stability 西姆莱斯有限公司 2025-05-20 CN claimed
EP-4547209-A1 MIXTURES COMPRISING CLIMBAZOLE WITH IMPROVED FOAM VOLUME AND STABILITY Symrise AG (DE) 2025-05-07 EP claimed
CN-115697965-B Concentrated liquid esterquat compositions 斯蒂潘公司 2025-05-06 CN claimed
WO-2025061274-A1 MIXTURES COMPRISING CLIMBAZOLE WITH IMPROVED FOAM VOLUME AND STABILITY SYMRISE AG (DE) 2025-03-27 WO claimed
CN-119571612-A High wear-resistant flame-retardant polyester fabric 常熟华贸纺织科技有限公司 2025-03-07 CN claimed
US-20250064783-A1 Compositions of Matter and Pharmaceutical Compositions PSILERA INC. 2025-02-27 US claimed
WO-2025011747-A1 3-HYDROXYPROPYLESTERS AS FOAM AND VISCOSITY MODULATING AGENTS IN SURFACTANT CONTAINING FORMULATIONS SYMRISE AG (DE) 2025-01-16 WO claimed
CN-118021640-A Liposome and preparation method and application thereof 广东省科学院化工研究所 2024-05-14 CN claimed
CN-101456744-B Preparation method of honeycomb type ceramic membrane UNIV SHANDONG TECHNOLOGY 2012-05-23 CN claimed
CN-102350304-A Preparation method of hollow fiber molecular sieve adsorbent material SHANGHAI STUFF SCIENCE AND TECHNOLOGY CO LTD 2012-02-15 CN claimed
CN-1279642-C Porous electrode of solid oxide fuel cell of asymmetric structure and its preparing method TAN XIAOYAO (CN) 2006-10-11 CN claimed
CN-1251345-C Method for preparing solid oxide fuel cell TAN XIAOYAO (CN) 2006-04-12 CN claimed
EP-1216036-B1 TRANSDERMAL ADMINISTRATION OF N-(2,5-DISUBSTITUTED PHENYL)-N'-(3-SUBSTITUTED PHENYL)-N'-METHYL GUANIDINES ALZA CORP (US) 2005-11-16 EP claimed
EP-1100476-B1 FORMULATIONS FOR THE TRANSDERMAL ADMINISTRATION OF FENOLDOPAM ALZA CORP (US) 2004-06-16 EP claimed
EP-1082084-B1 ANHYDROUS AEROSOL HAIRSPRAY COMPOSITIONS CONTAINING SILICONE GRAFTED COPOLYMERS PROCTER & GAMBLE (US) 2004-06-09 EP claimed
CN-1484335-A Method for preparing solid oxide fuel cell 谭小耀 2004-03-24 CN claimed
CN-1474469-A Porous electrode of solid oxide fuel cell of asymmetric structure and its preparing method 谭小耀 2004-02-11 CN claimed
EP-0804155-B1 COMPOSITION AND METHOD FOR ENHANCING TRANSDERMAL ELECTROTRANSPORT AGENT DELIVERY ALZA CORP (US) 2000-11-08 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250064783-A1 Compositions of Matter and Pharmaceutical Compositions TPH1, HTR1B, HTR2C FDPS 3121/4885SMPD1 184/4885CES2 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.